IUI1 Stock Overview

Develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. More details

IUI1 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 11.41% per year

Earnings grew by 47.9% over the past year

Risk Analysis

No risks detected for IUI1 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Intuitive Surgical, Inc. Competitors

Siemens Healthineers

XTRA:SHL

€58.3b

Carl Zeiss Meditec

XTRA:AFX

€4.0b

Eckert & Ziegler

XTRA:EUZ

€929.3m

Drägerwerk KGaA

XTRA:DRW3

€807.0m

Price History & Performance

Summary of share price highs, lows and changes for Intuitive Surgical
Historical stock prices
Current Share Price	US$507.50
52 Week High	US$532.70
52 Week Low	US$292.80
Beta	1.39
1 Month Change	-2.83%
3 Month Change	15.31%
1 Year Change	67.08%
3 Year Change	57.56%
5 Year Change	n/a
Change since IPO	11,103.09%

Recent updates

Shareholder Returns

	IUI1	DE Medical Equipment	DE Market
7D	-2.0%	-2.9%	-2.6%
1Y	67.1%	-8.5%	6.9%

Return vs Industry: IUI1 exceeded the German Medical Equipment industry which returned -8.5% over the past year.

Return vs Market: IUI1 exceeded the German Market which returned 6.9% over the past year.

Price Volatility

Is IUI1's price volatile compared to industry and market?
IUI1 volatility
IUI1 Average Weekly Movement	3.3%
Medical Equipment Industry Average Movement	6.6%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: IUI1 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: IUI1's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1995	13,676	Gary Guthart	www.intuitive.com

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.

Intuitive Surgical, Inc. Fundamentals Summary

How do Intuitive Surgical's earnings and revenue compare to its market cap?
IUI1 fundamental statistics
Market cap	€179.02b
Earnings (TTM)	€2.15b
Revenue (TTM)	€7.54b

83.3x

P/E Ratio

23.7x

P/S Ratio

Is IUI1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IUI1 income statement (TTM)
Revenue	US$7.87b
Cost of Revenue	US$2.60b
Gross Profit	US$5.27b
Other Expenses	US$3.03b
Earnings	US$2.24b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	6.30
Gross Margin	66.98%
Net Profit Margin	28.51%
Debt/Equity Ratio	0%

How did IUI1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 02:58
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Intuitive Surgical, Inc. is covered by 59 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
David Toung	Argus Research Company
null null	Argus Research Company
Richard Purkiss	Atlantic Equities LLP